Psykey, Inc. (CEOS)
OTCMKTS · Delayed Price · Currency is USD
0.0075
-0.0015 (-16.67%)
Jul 9, 2025, 4:00 PM EDT

Psykey Company Description

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life.

The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.

Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes.

The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021.

Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.

Psykey, Inc.
Country United States
Founded 2002
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 6
CEO Michael Maher

Contact Details

Address:
17 Belfield Road
Toronto, Nevada M9W1E8
Canada
Phone 888 376 8258
Website psykeyworld.com

Stock Details

Ticker Symbol CEOS
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US1500431077
SIC Code 3669

Key Executives

Name Position
Michael Maher Interim Chief Executive Officer
Amar Singh Bhatal Co-Founder, President, Secretary and Director
Sukhinderpaul Kalsi Co-Founder, Chief Financial Officer, Treasurer and Director
Jacqueline Rae Danforth Compliance Officer and Accountant
Mark Perkell Vice President and General Counsel
John Gustin Head of Global Business Development